Shock
Conditions
Keywords
Shock, Invasive mechanical ventilation, Fluid responsiveness, Heart-lung interactions, End-expiratory occlusion test, Newborns and infants
Brief summary
To date, the end-expiratory occlusion test in infants or children has never been evaluated as a marker of preload dependence. It therefore appears clinically relevant to evaluate this new indicator to predict fluid responsiveness in all infants hospitalized in pediatric and neonatal intensive care. The main objective of this study is to determine whether the hemodynamic effects of a 15-second end-expiratory occlusion were able to predict fluid responsiveness in the mechanically ventilated infant or newborn in pediatric intensive care.
Detailed description
Volume expansion remains one of the first resuscitation treatments for states of shock. Nonetheless, the decision to perform volume expansion should be based on a "functional" hemodynamic assessment, i.e., filling should only be performed if changes in cardiac preload result in significant changes in stroke volume. This is then referred to as preload dependency. Unnecessary volume expansion induces fluid overload and is associated with increased morbidity and mortality for shock conditions in infant and children. In addition, several studies in adults and children have demonstrated the lack of effectiveness of so-called "static" preload variables as witnesses of preload dependence. Only "dynamic" preload variables, based on the notion of cardiopulmonary interaction during mechanical ventilation, can predict this preload dependence, however with very variable sensitivities and specificities depending on the studies. The end-expiratory occlusion test is a dynamic preload dependency test that can be performed in patients on invasive ventilation. The test consists in interrupting the ventilator at end-expiration for 15 seconds, delaying the next insufflation thus allowing an increase in venous return to the right heart and then to the left heart. If the heart is preload dependent, an increase in venous return is accompanied by an increase in stroke volume and cardiac output (Franck-Starling's law). Volume expansion is usually considered effective or positive if cardiac output increases by more than 15% from baseline. To date, the end-expiratory occlusion test in infants or children has never been evaluated as a marker of preload dependence. It therefore appears clinically relevant to evaluate this new indicator to predict fluid responsiveness in all infants hospitalized in pediatric and neonatal intensive care. The main objective of this study is to determine whether the hemodynamic effects of a 15-second end-expiratory occlusion were able to predict fluid responsiveness in the mechanically ventilated infant or newborn in pediatric intensive care.
Interventions
The test consists in interrupting the ventilator at end-expiration for 15 seconds and assessing the resulting changes in cardiac output. Delays necessary to allow sufficient pulmonary transit time to allow good pulmonary venous return and therefore an increase in cardiac preload.
Sponsors
Assistance Publique - Hôpitaux de Paris
URC-CIC Paris Descartes Necker Cochin
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
0 Years to 2 Years
Healthy volunteers
No
Inclusion criteria
* Newborn and infant \<2 years. * Born at or near term (\> 36 weeks of amenorrhea). * Hospitalized in pediatric and neonatal intensive care. * Requiring the use of invasive mechanical ventilation. * In a state of shock defined by a cardio-circulatory dysfunction associating arterial hypotension, an alteration in organ perfusion, one or more organ dysfunctions or vasopressor's requirement. Clinical signs retained: heart rate ≥ 90th percentile associated with at least one sign of peripheral hypoperfusion represented by a a capillary refill time ≥ 3sec, or the presence of mottling or coldness of the extremities or urine output ≤ 0.5ml / kg / h or disturbance of consciousness. * The practitioner in charge of the patient has decided to perform volume expansion. * Non-opposition expressed by the holders of parental authority.
Exclusion criteria
* Any serious and urgent clinical hemodynamic situation, the management of which would be delayed by inclusion in the protocol. * Patient with unoperated congenital heart disease. * Patient in spontaneous or non-invasive ventilation or with spontaneous ventilatory cycles in invasive ventilation. * Patient in prolonged cardiac arrest (\> 5min) or refractory. * Patient under venous-arterial extracorporeal membrane oxygenation. * Refusal of the holders of parental authority to exploit the collected data.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Cardiac output | 25 minutes | Cardiac output measured by cardiac ultrasound before and during end-expiratory occlusion and after volume expansion. A positive response to end-expiratory occlusion is defined as an increase in cardiac output ≥ 15%. A positive response to the volume expansion test is defined as an increase in cardiac output ≥ 15%. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Heart rate | 25 minutes | Heart rate measured by cardiac ultrasound before and during end-expiratory pause and after volume expansion. |
| Systolic and diastolic blood pressures and mean arterial pressure | 25 minutes | Recorded using a bedside monitor before and during end-expiratory pause and after volume expansion. |
| Arterial pulse pressure | 25 minutes | Pressure waveform analysis was performed online with the soft tracing provided by the monitor. ∆PP (%) = PP max-PP min)/\[(PP max+PP min)/2\] × 100). |
| Stroke volume | 25 minutes | Measured by cardiac ultrasound before and during end-expiratory pause and after volume expansion. |
| Aortic velocity time integral | 25 minutes | Measured by cardiac ultrasound before and during end-expiratory pause and after volume expansion. |
| Aortic blood flow velocity | 25 minutes | Measured by cardiac ultrasound before and during end-expiratory pause and after volume expansion. |
Countries
France
Contacts
PRINCIPAL_INVESTIGATORYaël LEVY, MD
Assistance Publique - Hôpitaux de Paris
STUDY_DIRECTORPierre-Louis LEGER, MD, PhD
Assistance Publique - Hôpitaux de Paris
Outcome results
None listed